Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jose Antonio Lopez-Martin"'
Autor:
Javier Martin-Broto, Andres Redondo, David S. Moura, Claudia Valverde, Jose Manuel Morales, Antonio Lopez-Pousa, Javier Martinez-Trufero, Antonio Gutierrez, Roberto Díaz-Beveridge, Pablo Luna, Virginia Martinez-Marin, David Marcilla, Ivan Arribas, Patricio Ledesma, Jose Antonio Lopez-Martin, Davide Di Lernia, Jorge Zamora, Nadia Hindi
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
In patients with progressive and symptomatic desmoid fibromatosis (DF) treatment with chemotherapy is typically prolonged, while surgery carries a high risk of relapse. Here, the authors report the results of a phase II clinical trial of short-course
Externí odkaz:
https://doaj.org/article/fa55a5db19834abd945515a13986f8dd
Autor:
Maria Gonzalez-Cao, Clara Mayo de las Casas, Juana Oramas, Miguel A. Berciano-Guerrero, Luis de la Cruz, Pablo Cerezuela, Ana Arance, Eva Muñoz-Couselo, Enrique Espinosa, Teresa Puertolas, Roberto Diaz Beveridge, Sebastian Ochenduszko, Maria-Jose Villanueva, Laura Basterretxea, Lorena Bellido, Delvys Rodriguez, Begoña Campos, Clara Montagut, Ana Drozdowskyj, Miguel A. Molina, Jose Antonio Lopez-Martin, Alfonso Berrocal
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-6 (2021)
Whether intermittent strategies of delivering drugs can improve cancer patients survival is still unclear. Here, the authors reports the results of a randomized phase II clinical trial aimed to compare the efficacy and safety of two dosing regimens (
Externí odkaz:
https://doaj.org/article/bcf9c314e06143fd83f1b0b564d0166e
Autor:
Mónica Patricia Cala, María Teresa Agulló‐Ortuño, Elena Prieto‐García, Carolina González‐Riano, Lucía Parrilla‐Rubio, Coral Barbas, Carmen Vanesa Díaz‐García, Antonia García, Cristina Pernaut, Jorge Adeva, María Carmen Riesco, Francisco Javier Rupérez, Jose Antonio Lopez‐Martin
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 9, Iss 2, Pp 348-357 (2018)
Abstract Background Cachexia is a metabolic syndrome that affects up to 50–80% of cancer patients. The pathophysiology is characterized by a variable combination of reduced food intake and abnormal metabolism, including systemic inflammation and ne
Externí odkaz:
https://doaj.org/article/791db3b470124f629a82a0db56bc1604
Autor:
Saurabh P. Nagar, Daniel S. Mytelka, Sean D. Candrilli, Yulia D’yachkova, Maria Lorenzo, Bernd Kasper, Jose Antonio Lopez-Martin, James A. Kaye
Publikováno v:
Sarcoma, Vol 2018 (2018)
Objective. To describe real-world treatment patterns and outcomes for patients with advanced soft tissue sarcoma (STS) not amenable to surgery or radiotherapy in the United Kingdom, Spain, Germany, and France. Methods. Physicians completed a web-base
Externí odkaz:
https://doaj.org/article/3a3db765c7364d779e85984436710234
Autor:
Daniel S. Mytelka, Saurabh P. Nagar, Yulia D’yachkova, Elizabeth M. La, James A. Kaye, Sean D. Candrilli, Bernd Kasper, Jose Antonio Lopez-Martin, Maria Lorenzo
Publikováno v:
Sarcoma, Vol 2018 (2018)
Objective. To describe health care resource utilization and costs for patients with advanced soft tissue sarcoma (STS) in the United Kingdom (UK), Spain, Germany, and France. Methods. Physicians abstracted data for adult patients with a diagnosis of
Externí odkaz:
https://doaj.org/article/05c135348ffc4269ad5231c6254d7b9d
Autor:
Patrick Schöffski, Vincente Guillem, Margarita Garcia, Fernando Rivera, Josep Tabernero, Martin Cullell, Jose Antonio Lopez-Martin, Patricia Pollard, Herlinde Dumez, Xavier Garcia del Muro, Luis Paz-Ares
Publikováno v:
Marine Drugs, Vol 7, Iss 1, Pp 57-70 (2009)
This randomized phase II study evaluated two schedules of the marine compound Plitidepsin with or without co-administration of L-carnitine in patients with renal cell carcinoma. Patients had adequate performance status and organ function.The primary
Externí odkaz:
https://doaj.org/article/8d530fe117404dc39c64e1e9c569f6f0
Autor:
Sen Hong Zhuang, Roland Knoblauch, Zhilong Yuan, Brett Hall, Suso Platero, Ludy van Beijsterveldt, Jaume Capdevila, Jose Antonio Lopez-Martin, Andrés Cervantes, Patrick Schöffski, Luc Dirix, Josep Tabernero
Purpose: Originally isolated on the basis of its ability to induce p53, serdemetan showed potent activity in various preclinical models, inducing S-phase arrest and apoptosis in TP53 wild-type and mutant tumors. This study evaluated the safety and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f61b6e0f3b9e6b5565701cec26e218b
https://doi.org/10.1158/1078-0432.c.6519323.v1
https://doi.org/10.1158/1078-0432.c.6519323.v1
Autor:
Andrea García-Lizarribar, Aranzazu Villasante, Jose Antonio Lopez-Martin, Marta Flandez, M. Carmen Soler-Vázquez, Dolors Serra, Laura Herrero, Ana Sagrera, Alejo Efeyan, Josep Samitier
Publikováno v:
Biomaterials Advances. 150:213426
Autor:
Andrea García-Lizarribar, Aranzazu Villasante, Jose Antonio Lopez-Martin, Marta Flandez, M. Carmen Soler-Vázquez, Dolors Serra, Laura Herrero, Josep Samitier
Publikováno v:
SSRN Electronic Journal.
Autor:
Sean D. Candrilli, James A. Kaye, Yulia Dyachkova, Elizabeth M. La, Saurabh P Nagar, Daniel S. Mytelka, Bernd Kasper, Maria J. Lorenzo, Jose Antonio Lopez-Martin
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Sarcoma, Vol 2018 (2018)
Sarcoma
Consejería de Sanidad de la Comunidad de Madrid
Sarcoma, Vol 2018 (2018)
Sarcoma
Objective. To describe health care resource utilization and costs for patients with advanced soft tissue sarcoma (STS) in the United Kingdom (UK), Spain, Germany, and France. Methods. Physicians abstracted data for adult patients with a diagnosis of